Skip to main content
GHW International logo

GHW International — Investor Relations & Filings

Ticker · 9933 ISIN · KYG3854D1051 HKEX Manufacturing
Open in API
Filings indexed 221 across all filing types
Latest filing 2023-03-01 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 9933

About GHW International

http://www.goldenhighway.com

GHW International is a high-tech manufacturing enterprise and investment holding company specializing in the research, development, production, and global sale of chemical and pharmaceutical products. The company functions as an integrated service provider of applied chemical intermediates, serving customers worldwide across major markets including Asia and Europe. Its core product portfolio encompasses specialized fine chemicals, polyurethane materials (such as adhesives and sealants), animal nutrition chemicals, and pharmaceutical intermediates. Key product lines include globally recognized iodine derivatives, choline chloride, and methylamine industry series. GHW leverages capital empowerment and industrial chain synergy, positioning itself as a high-tech enterprise focused on specialized, high-growth chemical solutions.

Recent filings

Filing Released Lang Actions
ADOPTION OF SHARE AWARD PLAN
Capital/Financing Update Classification · 95% confidence The document is an announcement by GHW International regarding the adoption of a Share Award Plan. It details the purpose, administration, eligibility, shares pool, award of shares, voting rights, vesting, blackout periods, lapse of awards, and plan limits. The content focuses on the establishment and terms of a share award scheme governed by listing rules, without presenting financial statements or results. It is not a financial report, earnings release, or management discussion. It is also not a proxy solicitation or voting results announcement. The document is a regulatory announcement about a capital-related plan (share award plan) but does not announce a new share issue or capital change per se. The best fitting category is Capital/Financing Update (CAP) because it relates to the company's capital structure and share awards, which are financing-related activities.
2023-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities for the month ended 31 January 2023. It details movements in authorized and issued share capital, share options, and confirms compliance with listing rules. The document is structured as a regulatory submission with no financial statements or management discussion. It is not an annual or interim report, earnings release, or investor presentation. It is a regulatory filing reporting share capital movements and confirmations related to securities issuance. Therefore, it fits best under Regulatory Filings (RNS).
2023-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return concerning movements in securities, specifically focusing on authorized and issued share capital, share options, and confirmations related to securities issued by the company. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is regulatory in nature, reporting share capital and share option movements for the month ended 31 December 2022. It does not contain financial statements, management discussion, or earnings data. It is not an announcement of a report but a regulatory submission of share capital movements. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-01-03 English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
Remuneration Information Classification · 95% confidence The document is titled 'TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE OF THE BOARD OF DIRECTORS' and details the membership, authority, duties, and procedures of the Remuneration Committee. It is a governance document outlining the committee's role in setting and reviewing remuneration policies for directors and senior management. There is no financial data, earnings information, or report publication mentioned. The content is focused on governance and remuneration policies rather than executive compensation disclosures or proxy materials. Therefore, it fits best under Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors, including committee terms of reference related to remuneration.
2023-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities, specifically focusing on authorized and issued share capital, share options, and confirmations related to securities issued by the issuer. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is regulatory in nature, reporting share capital and share issuance movements for the month ended 30 November 2022. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report but a regulatory filing of share capital movements and confirmations. Therefore, the document fits best under Regulatory Filings (RNS) as it is a compliance and disclosure document related to securities movements under exchange rules.
2022-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities for the month ended 31 October 2022. It details movements in authorized and issued share capital, share options, and confirms compliance with listing rules. The document is regulatory in nature, reporting share capital and share issuance movements, but it is not a full financial report, earnings release, or management discussion. It is a regulatory filing related to share capital movements and confirmations, typical of filings under exchange listing rules. It does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update, but rather fits the general category of Regulatory Filings (RNS) as it is a compliance and disclosure document submitted to the exchange without substantive financial statements or management commentary.
2022-11-01 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.